Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of a I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Using PROBE Design

NCT01704586 is registered in ClinicalTrials.gov with University of Wuerzburg as lead sponsor.

NCT NCT01704586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01704586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of a I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Using PROBE Design
Lead sponsor
University of Wuerzburg
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 31, 2015
Completion date
May 31, 2031
Enrollment
340 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

differentiated thyroid carcinoma